Since my last Eli Lilly ( LLY ) analysis , the stock has gained 25% in price. This business is de facto becoming the dominant global cardiometabolic platform, f...
Market Samachar is a news aggregator. This article was originally published by seekingalpha.com. Tap the button above to read the full story on their site.